MiNK Therapeutics Achieves Breakthrough in Cancer Therapy

MiNK Therapeutics shares are trading higher after announcing complete remission in a metastatic testicular cancer patient following their allogeneic iNKT cell therapy. This breakthrough demonstrates the potential of iNKT cells in challenging cancer treatments.